Medopad Provides its Remote Patient Monitoring Platform to Support Global COVID-19 Pandemic
Shots:
- Medopod’s RPM platform will be available for NHS Trusts across the UK as well as global healthcare providers that allow doctors to track patient’s data- symptom progression and flag patients with worsening symptoms- both inside and outside of clinical settings
- Patients will use the app to share their personal data such as temperature- respiration rate and heart rate. Medopad has worked with Imperial College- Guys and St Thomas’ NHS Foundation Trust- as well as Johns Hopkins University to create the specialist RPM platform for tracking COVID-19
- The Medopod’s RPM software is CE marked and under FDA enforcement discretion and is geared up to be deployed across the EU- US- China- Singapore- Hong Kong and Saudi Arabia
Click here to read full press release/ article | Ref: PRweb | Image: PRweb
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com